Publications (46)107.95 Total impact
-
Article: Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project.
[show abstract] [hide abstract]
ABSTRACT: The Japan Cancer Surveillance Research Group estimated the cancer incidence in 2006 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 15 of 32 population-based cancer registries. The total number of incidences in Japan for 2006 was estimated as 664 398 (C00-C96). The leading cancer site was stomach for men and breast for women. Age-standardized incidence rates remained at almost the same level as for the previous 3 years.Japanese Journal of Clinical Oncology 12/2011; 42(2):139-47. · 1.78 Impact Factor -
Article: Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.
[show abstract] [hide abstract]
ABSTRACT: The Japan Cancer Surveillance Research Group estimated the cancer incidence in 2005 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 12 of 30 population-based cancer registries. The total number of incidences in Japan for 2005 was estimated as 646,802 (C00-C96). The leading cancer site was the stomach for men and the breast for women. Age-standardized incidence rates remained almost the same level as the previous 2 years.Japanese Journal of Clinical Oncology 01/2011; 41(1):139-47. · 1.78 Impact Factor -
Article: Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study.
[show abstract] [hide abstract]
ABSTRACT: The purpose of the present study was to collect data from population-based cancer registries and to calculate relative 5-year survival of cancer patients in Japan. We also sought to determine time trends and to compare the results with international studies. We asked 11 population-based cancer registries to submit individual data for patients diagnosed from 1993 to 1999, together with data on outcome after 5 years. Although all these registries submitted data (491 772 cases), only six met the required standards for the quality of registration data and follow-up investigation. The relative 5-year survival calculated by pooling data from 151 061 cases from six registries was taken as the survival for cancer patients in Japan. Relative 5-year survival (1997-99) was 54.3% for all cancers (males: 50.0%, females: 59.8%). Survival figures for all sites changed slightly over the 7-year period, from 53.2% for the first 4 years of the study (1993-96) to 54.3% for the last 3 years (1997-99), however, a major improvement was observed in several primary sites. Some overall survival was lower in Japan than in the USA, but similar to that in European countries. Specifically, survival for uterine cancer, prostate cancer, testis cancer, lymphoma and leukemia was much lower in Japan than in other countries. However, survival was better in Japan mainly for cancers of the esophagus, stomach, colon, liver and gallbladder. The study suggests an improvement in cancer survival in several primary sites in Japan, which is consistent with the development of treatments and early detection.Japanese Journal of Clinical Oncology 01/2011; 41(1):40-51. · 1.78 Impact Factor -
Article: Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
[show abstract] [hide abstract]
ABSTRACT: The Japan Cancer Surveillance Research Group estimated the cancer incidence in 2004 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 14 of 31 population-based cancer registries. The total number of incidences in Japan for 2004 was estimated as 623,275 (C00-C96). The leading cancer site according to the crude and age-standardized incidence rates was the stomach for men and breast for women. The apparent increase in age-standardized incidence rates in 2003 was calmed down in 2004.Japanese Journal of Clinical Oncology 12/2010; 40(12):1192-200. · 1.78 Impact Factor -
Article: Do the Japanese feel more suspicious about cancer registration than the British?
[show abstract] [hide abstract]
ABSTRACT: Cancer registration is indispensable, providing useful statistical measures for the appropriate evaluation of cancer control programs and medical treatment or screening. Following the British national survey on attitudes toward cancer registration, we conducted an investigation to correctly evaluate the general opinion of the Japanese population in this regard. We randomly recruited 3000 men and women aged 20-69 years from a research database. Only 4% of all respondents had heard about the cancer registry system before the investigation. However, 77% of respondents thought that cancer registration was useful. Forty-three percent of respondents answered, regardless of the strictness of the data protection, that privacy had been violated if the registration occurred without an individual explanation. Compared with the British survey results, Japanese people seemed to be more suspicious about the largely unknown system of cancer registry. Nonetheless, it is noteworthy that Japanese respondents did not show active opposition to cancer registration; they tended to choose "I don't know" instead of "no" to questions asking if they supported the registry system. Multivariate analysis showed that male sex, older age, and living in the southern region were the factors significantly associated with support for cancer registration. We can seek society's understanding toward cancer registration by actively utilizing information from cancer registries, by using examples of how data are actually used that have wide appeal, and by educating the public on how the data are treated under the complete privacy policy.Cancer epidemiology. 03/2010; 34(2):122-30. -
Article: Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database.
Japanese Journal of Clinical Oncology 12/2009; 39(12):860-1. · 1.78 Impact Factor -
Article: Comparison of time trends in lung cancer mortality (1990-2006) in the world, from the WHO Mortality Database.
Japanese Journal of Clinical Oncology 10/2009; 39(10):696-7. · 1.78 Impact Factor -
Article: Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
Japanese Journal of Clinical Oncology 10/2009; 39(12):850-8. · 1.78 Impact Factor -
Article: Comparison of time trends in colon, rectum and anus cancer incidence (1973-2002) in Asia, from 'Cancer Incidence in Five Continents, Vols IV-IX'.
Japanese Journal of Clinical Oncology 04/2009; 39(3):196-8. · 1.78 Impact Factor -
Article: Comparison of time trends in lung cancer incidence (1973-2002) in Asia, from cancer incidence in five continents Vols IV-IX.
Japanese Journal of Clinical Oncology 03/2009; 39(2):133-5. · 1.78 Impact Factor -
Article: Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies.
[show abstract] [hide abstract]
ABSTRACT: Quantitative measures of the burden of tobacco smoking in Asian countries are limited. We estimated the population attributable fraction (PAF) of mortality associated with smoking in Japan, using pooled data from three large-scale cohort studies. In total, 296,836 participants (140,026 males and 156,810 females) aged 40-79 years underwent baseline surveys during the 1980s and early 1990s. The average follow-up period was 9.6 years. PAFs for all-cause mortality and individual tobacco-related diseases were estimated from smoking prevalence and relative risks. The prevalence of current and former smokers was 54.4% and 25.1% for males, and 8.1% and 2.4% for females. The PAF of all-cause mortality was 27.8% [95% confidence interval (CI): 25.2-30.4] for males and 6.7% (95% CI: 5.9-7.5) for females. The PAF of all-cause mortality calculated by summing the disease-specific PAFs was 19.1% (95% CI: 16.0-22.2) for males and 3.6% (95% CI: 3.0-4.2) for females. The estimated number of deaths attributable to smoking in Japan in 2005 was 163,000 for males and 33,000 for females based on the former set of PAFs, and 112,000 for males and 19,000 for females based on the latter set. The leading causes of smoking-attributable deaths were cancer (61% for males and 31% for females), ischemic heart diseases and stroke (23% for males and 51% for females), and chronic obstructive pulmonary diseases and pneumonia (11% for males and 13% for females). The health burden due to smoking remains heavy among Japanese males. Considering the high prevalence of male current smokers and increasing prevalence of young female current smokers, effective tobacco controls and quantitative assessments of the health burden of smoking need to be continuously implemented in Japan.Journal of Epidemiology 01/2009; 18(6):251-64. · 1.86 Impact Factor -
Article: A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004).
[show abstract] [hide abstract]
ABSTRACT: Cancer is one of the major targets of disease control programs in Japan. A Joinpoint regression model was used to analyze the long-term trends of mortality related to overall cancer and the 15 most common cancers based on published data from the National Vital Statistics of Japan between 1958 and 2004. Since 1996, a decline has been seen in overall cancer for both sexes in Japan. Most of the common sites, including cancers of the stomach, colon, liver, gallbladder and lung and leukemia in both sexes, cancer of esophagus in men and rectal and ovarian cancers in women showed a decreasing trend, and cancers of the rectum, pancreas, prostate and urinary bladder and malignant lymphoma in men and cancers of the esophagus and uterus in women leveled off during the most recent period. However, an increasing trend was confirmed for cancers of the pancreas, breast and urinary bladder and malignant lymphoma in women. An effective cancer control program including prevention, early detection and treatment should be implemented to further reduce the cancer mortality, particularly for cancer sites that show higher mortality rates or increasing trends.International Journal of Cancer 11/2008; 124(2):443-8. · 5.44 Impact Factor -
Article: Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies.
[show abstract] [hide abstract]
ABSTRACT: Better information on lung cancer occurrence in lifelong nonsmokers is needed to understand gender and racial disparities and to examine how factors other than active smoking influence risk in different time periods and geographic regions. We pooled information on lung cancer incidence and/or death rates among self-reported never-smokers from 13 large cohort studies, representing over 630,000 and 1.8 million persons for incidence and mortality, respectively. We also abstracted population-based data for women from 22 cancer registries and ten countries in time periods and geographic regions where few women smoked. Our main findings were: (1) Men had higher death rates from lung cancer than women in all age and racial groups studied; (2) male and female incidence rates were similar when standardized across all ages 40+ y, albeit with some variation by age; (3) African Americans and Asians living in Korea and Japan (but not in the US) had higher death rates from lung cancer than individuals of European descent; (4) no temporal trends were seen when comparing incidence and death rates among US women age 40-69 y during the 1930s to contemporary populations where few women smoke, or in temporal comparisons of never-smokers in two large American Cancer Society cohorts from 1959 to 2004; and (5) lung cancer incidence rates were higher and more variable among women in East Asia than in other geographic areas with low female smoking. These comprehensive analyses support claims that the death rate from lung cancer among never-smokers is higher in men than in women, and in African Americans and Asians residing in Asia than in individuals of European descent, but contradict assertions that risk is increasing or that women have a higher incidence rate than men. Further research is needed on the high and variable lung cancer rates among women in Pacific Rim countries.PLoS Medicine 10/2008; 5(9):e185. · 16.27 Impact Factor -
Article: Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries.
[show abstract] [hide abstract]
ABSTRACT: The number of cancer incidences, crude incidence rates, age-standardized incidence rates in 2002 in Japan are estimated. The estimated total number of incidences was 570,598.Japanese Journal of Clinical Oncology 10/2008; 38(9):641-8. · 1.78 Impact Factor -
Article: Lifetime and age-conditional probabilities of developing or dying of cancer in Japan.
[show abstract] [hide abstract]
ABSTRACT: The concepts of lifetime and age-conditional probabilities of developing and dying of cancer are introduced as indexes to understand the risk of cancer. In this paper, we estimated the lifetime and age-conditional probabilities of developing and dying of cancer in 2001 and 2005, respectively, in Japan. It is estimated that one in two Japanese males and one in three females will develop cancer, and one in four Japanese males and one in six females will die of cancer. Moreover, the probabilities of developing cancer within specific decades of age are obtained as the short-term risks.Japanese Journal of Clinical Oncology 09/2008; 38(8):571-6. · 1.78 Impact Factor -
Article: Comparison of time trends in kidney cancer incidence (1973-97) in East Asia, Europe and USA, from cancer incidence in five continents, Vols IV-VIII.
Japanese Journal of Clinical Oncology 08/2008; 38(7):508-9. · 1.78 Impact Factor -
Article: Comparison of time trends in lip cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents, Vols IV-VIII.
Japanese Journal of Clinical Oncology 07/2008; 38(6):456-7. · 1.78 Impact Factor -
Article: Comparison of time trends in larynx cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents, Vols. IV-VIII.
Japanese Journal of Clinical Oncology 05/2008; 38(4):324-5. · 1.78 Impact Factor -
Article: Comparison of time trends in skin cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII.
Japanese Journal of Clinical Oncology 04/2008; 38(3):234-6. · 1.78 Impact Factor -
Article: Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries.
Japanese Journal of Clinical Oncology 12/2007; 37(11):884-91. · 1.78 Impact Factor
Top co-authors
Top Journals
Institutions
-
2003–2011
-
National Cancer Center
- • Center for Cancer Control and Information Services
- • Research Center for Cancer Prevention and Screening
Tokyo, Tokyo-to, Japan
-
-
2008
-
Sapporo Medical University
- Department of Liberal Arts and Sciences
Sapporo-shi, Hokkaido, Japan
-
-
2007
-
Aichi Cancer Center
ลsaka-shi, Osaka-fu, Japan
-
